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Abstract
Background: Tuberculosis remains to be a major public health problem among under developed world due to
delay in detection and treatment of patients with active TB. In Ethiopia, tuberculosis has been recognized as a
major public health problem for more than fifty years.
Objective: The main objective of this study was to determine treatment outcomes and associated factors among
TB patients attending Nigist Eleni Mohammed General Hospital, Hosanna, SNNPR, Ethiopia.
Methods: A five years medical records on treatment outcomes of tuberculosis was reviewed by using a retrospective
study design. A total of 768 tuberculosis patients’ cards registered in TB unit register from June 2009 to August 2014
were reviewed. Data was coded, cleaned and entered into a computer data base by using EPI Info version 3.5.3 and
then analysed by using Spss version 20.0 Descriptive summary values such as frequency and percentage was used to
describe the study variable. Moreover, bivariate and multivariate logistic regression analysis with a confidence level of
95% was performed in order to determine the final predictors of the outcome variable. Association of age,
sex, residence, HIV status of the patient and TB type/category was assessed with the TB treatment outcome
through bivariate analysis. And residence, TB category and HIV status were found significantly associated with
the treatment outcomes in bivariate analysis. Finally, the forward addition model was used for the multivariate
analysis, and residence, TB category and HIV status of TB patient were entered into the final model to obtain
an adjusted odds ratio (AOR).
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Result: Out of 768 TB patients who were registered at the hospital during the study period, 249 (32.4%) completed
the treatment, 84 (10.9%) cured, 11 (1.4%) defaulted, 397 (51.7%) were transferred out to other health facility, 23 (2.9%)
died and 4 (0.5%) failed the treatment regimen. In this study, the overall treatment success of TB was 333 (43.3%) as
compared to their counterparts, 435 (56.7%). Patients who presented pulmonary TB + ve were more likely to develop
risk of poor treatment outcomes as compared to the patients with extra pulmonary TB and pulmonary TB-ve (AOR = 1.
915,95% CI;1.213,3.028). The proportion of TB HIV co-infection was16.4%, and HIV + ve TB patients were more likely to
develop risk of poor treatment outcomes as compared to their counterparts (AOR = 0.796, 95% CI;0.512,1.236).
Conclusion: From this study, it was generally observed that the rate of defaulting was very low in the hospital. On the
other hand, it was observed that the rate of transfer out of patients from the hospital to other health care facilities was
very high during the study period. Furthermore, it was observed that patients who came from urban area were less
likely to develop risk of poor treatment outcomes as compared to patients who reside in the rural areas.
Keywords: TB, Treatment outcome
Background
Tuberculosis is one of the oldest disease that affect hu-
man and the leading cause of death globally. It is caused
by Mycobacterium tuberculosis mainly affecting the
lungs, but can affect other sites as well and it is curable
if properly treated. World Health Organisation (WHO)
declared tuberculosis as a global public health emer-
gency by the year 1993 and DOTS program has been
promoted as a control strategies [1]. Unlike the availabil-
ity of an appropriate prevention and control strategies,
tuberculosis continues to challenge the world by its inci-
dence and mortality fueled by HIV pandemic and drug
resistant TB. The burden of the disease doubles in Africa
due to theHIV and a low coverage of HIV testing [2].
The success of TB treatment is the sum of the patients
who are cured and those who have completed treatment
under the Directly Observed Therapy Short Course
(DOTS) strategy. In 1995 Directly Observed Therapy
Short Course (DOTS) was initiated for the first time in
some areas of Southern Nations Nationalities and Peo-
ples Region and the program has raised the case detec-
tion and treatment success rate by folds. However,
tuberculosis (TB) remains the leading cause of morbidity
and mortality in the region and it is the third cause of
inpatient death in the region. Studies conducted in the
region revealed that the mortality is higher in the first 2
months of treatment [3].
In the southern region of Ethiopia, tuberculosis was
the third cause of death in hospitalized patients. Re-
searches revealed that the mortality rate was 2.5% per
annum in successfully treated tuberculosis patients in
SNNPR [3].
Although the key target of TB control in DOTs is to
detect the disease and treat the cases, delayed presenta-
tion for treatment, incomplete treatment or poor com-
pliance as well as treatment interruption or default,
relapse, and death are the major challenge that TB pro-
grammes face in resource-constrained countries [4].
Moreover, the federal ministry of health (FMOH) re-
ported in 2011 that tuberculosis was the third leading
cause of death in Ethiopia. World Health Organisation
(WHO) global report in 2012 estimated that there were
8.7 million new cases and 12 million prevalent cases of
tuberculosis globally in 2011 [5]. The DOTs strategy, de-
veloped by the WHO for the prevention and control of
TB in the early 1995s, was believed to be the most valu-
able strategy; and a cost-effective health intervention for
reducing the incidence and death of TB in developing
countries [5].
It is estimated that approximately one-third of the
world’s population is infected with mycobacterium tu-
berculosis. Death from active form of tuberculosis is ex-
pected to increase to 5 million by the year 2015. The
burden the disease will be expected to be much higher
in sub-Saharan African countries. The main reasons for
the high morbidity and mortality of TB in these regions
are dramatic increase in poverty, HIV epidemic, and
emergence of drug resistant TB [6].
According to the 2011 national population survey of
Ethiopia, there were an estimated 15,000 deaths due to
tuberculosis [7].
Ethiopia was ranked 7th in the world for TB burden and
3rd in Africa in 2008, with an estimated TB incidence (all
forms) of 378 new cases per 100,000 persons and163 new
smear positive cases per 100,000 persons [8].
A study conducted among 6580 registered tuberculosis
patients (3147 males and 3433 females) in Addis Ababa
health centers showed the following treatment out-
comes: 18.1% cured, 64.6% completed treatment, 3.7%
died during follow-up, 5.1% defaulted, 0.4% failed the
treatment and 8.2% were transferred out to another
health institution. From this study, it was found that year
of enrollment was significantly associated with the treat-
ment success [8].
A study conducted in Uganda revealed that a limited
information of patients about the disease resulted in
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high rate of defaulting and Mortality. Among 657 TB pa-
tients to assess a long term outcome of smear positive
TB. Accordingly, 326 (49.6%) interrupted 1or more
times. Of which 95 (29.1%) were in intensive phase, 82
(25.2%) in continuation phase and 149 (45.1%) inter-
rupted their treatment in both phases [9]. WHO esti-
mates that 1.9% of all new TB cases may be resistant to
the first line anti-tuberculosis drugs while about 9.4%
TB cases may be resistance to the previously treated
drugs. In patients on anti-tuberculosis drug therapy,
poor adherence is recognized as a major cause of treat-
ment failure, relapse and drug resistance [10].
In another study conducted in Ibadan, Nigeria, the fol-
lowing proportion of treatment outcomes were ob-
served: cure (76.6%), failure (8.1%), default (6.6%),
transferred out (4.8%), and death (1.9%). The mean age
of cured patients was 31.2±3.1 years, which was signifi-
cantly lower than the mean age of those with poor treat-
ment outcomes. In this study, males had a higher risk of
a poor treatment outcome than females. Moreover, pa-
tients with a poor knowledge of tuberculosis had a
higher risk of having a poor treatment outcome com-
pared to those with a good knowledge about the disease
[11].
According to the study conducted in the central part
of Ethiopia, the outcome of smear positive pulmonary
TB treatment success rate was higher as compared to
the WHO targets and showed 10.8% of unfavorable out-
come. The unsuccessful treatment outcome was also
higher in age groups more than 40, family size>5,
retreatment and unemployed compared to their inverse
[12].
One study conducted on treatment outcome of tuber-
culosis patients under directly observed treatment and
another five years retrospective study conducted on
childhood tuberculosis and its treatment outcomes in
Addis Ababa at various times showed almost similar in-
creasing proportions of smear positive PTB, smear nega-
tive PTB and EPTB [13, 14].
Treatment outcomes were documented for 95.2% of
children of whom 85.5% were successfully treated while
rates of mortality and defaulting from treatment was
3.3% and 3.8%, respectively. The proportion of children
with TB tested for HIV reached 88.3% during the final
year of the study period compared to only 3.9% at the
beginning of the study period [14].
Mortality was significantly higher among under-five
children (p < 0.001) and those with HIV co-infection (p
<0.001). On multivariate logistic regression, children 5–9
years [AOR = 2.50 (95% CI 1.67-3.74)] and 10–14 years
[AOR = 2.70 (95% CI 1.86–3.91)] had a significantly
higher successful treatment outcomes. On the other
hand, smear positive PTB [AOR = 0.44 (95% CI 0.27–
0.73), HIV co-infection (AOR = 0.49 (95% CI 0.30–
0.80)] and unknown HIV sero-status [AOR = 0.60 (95%
CI 0.42-0.86)] were predictors of poor treatment out-
comes [14].
From the study conducted in Mizan Aman hospital, it
was found that out of 2043 TB patients, male patients
outweighed (58.00%) female patients (42.00%). The fol-
lowing treatment outcomes were also observed in this
study: 79 (3.87%) cured, 4 (0.20%) defaulted, 1575
(76.99%) transferred out to other health facility, and 25
(1.22%) died [15].
Despite the continued DOTS TB treatment practice in
Hadiya zone, treatment outcomes have not been
assessed yet in the area. Therefore, the aim of this study
was to assess treatment outcomes of TB patients and as-
sociated factors in the past five years in Nigist Eleni Mo-
hammed general hospital, Hossana, SNNPR, Ethiopia.
Methods
Study area
The study was conducted in Hossana town, Nigist Eleni
Mohammed General Hospital (NEMGH). Hossana is cap-
ital of Hadiya zone, which is situated 232kms Southwest
of Addis Ababa with an average elevation of 2276 m above
the sea level. The town has a total area of 23 sq.km
(Hossana Municipality). Based on the 2007 census re-
port, its total population was estimated to be 92,733
in 2011 (Zonal report,2007).
Study design
A retrospective study was conducted from June 2009 to
August 2014 among TB patients who were under treat-
ment in the year before August 30/2014 in Nigist Eleni
Mohammed general hospital, Hossana.
Study population
The study population was all patient cards/charts of tu-
berculosis registered and put on DOTS in the hospital
during the study period
Inclusion criteria
All patient cards/charts of tuberculosis registered form
June 2009 and completed before August 2014.
Exclusion criteria
Incomplete patient cards were excluded from the study.
Data collection tool
Medical records were reviewed by using a structured
data sheet prepared in English. A treatment outcome
was evaluated in accordance with the National Tubercu-
losis and Leprosy Control Program (NTLCP) adopted
from the WHO.
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Data quality assurance
To assure the quality of data, data collectors and supervi-
sors were selected based on their educational status and
experience in a TB clinic. After giving a one day’s training
for data collectors and supervisors, strict supervision was
assumed, mean while any doubts in the questionnaire/
checklist was clarified.
Data processing and data analysis
After data collection, each structured data sheet was
checked for its completeness before the data entry. Data
was coded, edited and entered into a computer database
by using EPI Info version 3.5.3 and then analysed by
using Spss version 20.0. Descriptive summary values
such as frequency and percentage was used to describe
the study variable. Moreover, bivariate and multivariate
logistic regression analyses with a confidence level of
95% was performed in order to determine the final pre-
dictors of the outcome variable. Variables with p-value
< 0.05 in the bivariate analysis were transferred into
multivariate logistic regression analysis. Finally adjusted
odds ratios with their 95% confidence intervals and
explanatory variables with p-value of 0.05 were consid-




TB Treatment out come.
Independent variable
Age, Sex, residence, TB type/category, HIV status.
Ethical consideration
Before the study begins ethical clearance was obtained
from ethical and research approval committee of Hos-
sana Collage of Health Sciences. Official permission was
secured from authority of the hospital. To maintain
confidentiality, names or other identifiers of study par-
ticipants were not included.
Limitations of the study
Since the source of data is secondary, the quality issue is
always the question leading to certain disorganization of
the required information. Because of the incompleteness
of some of patient records in this hospital, the study
couldn’t address other common risk factors other than
the variables included in this study.
Strengths of the study
This study used structured and standardized data sheet
to collect information on TB treatment outcomes. More-
over, this study used only complete patient records to
determine and evaluate TB treatment outcomes and
associated factors in accordance with the National Tu-
berculosis and Leprosy Control Program of the WHO.
Furthermore, clear-cut recommendations or policy guide
was forwarded by this study.
Result
A total of 768 TB patients were registered at Hossana
Nigist Eleni Mohammed general hospital (NEMGH)
from June 2009 to August 2014. Of these, 425 (55.3%)
were males and 343 (44.7%) were females.
Among the study participants, 208 (27.1%) were in the
age group from 25 – 34 years. Out of the total 768 cases,
411 (53.5%) came from rural areas. Regarding TB classifi-
cations, about 497 (64.3%) were smear negative pulmonary
TB cases.
In terms of patients category 651 (84.8%) were pul-
monary TB and 111 (15.2%) were extra pulmonary TB.
About 125 (16.5%) of the study participants were HIV
positive. TB cases were categorized into new and previ-
ously treated, and the majority of them (94.3%) were
new cases [Table 1].
Treatment Outcomes
Out of 768 TB patients who were registered at the hos-
pital during the study period, 249 (32.4%) completed the
treatment, 84 (10.9%) cured, 11 (1.4%) defaulted, 395
(51.7%) were transferred out to other health facility, 22
(2.9%) died and 4 (0.5%) failed the treatment regimen.
The treatment success rate (it was computed as: com-
pleted the treatment with negative TB bacteria result
(cured) plus completed the treatment but without
bacteriology result at the end of treatment) was 333
(43.3%) as compared to their counterparts, 435 (56.7%)
[Table 2].
Factors associated with treatment outcome of
tuberculosis
Association of age, sex, residence, HIV status of the pa-
tient and TB type/category was assessed with the TB treat-
ment outcome through bivariate analysis. And residence,
TB category and HIV status were found significantly asso-
ciated with the treatment outcomes in bivariate analysis.
Finally, the forward addition model was used for the
multivariate analysis, and residence, TB category and HIV
status of TB patient were entered into the final model to
obtain an adjusted odds ratio (AOR). Those patients who
came from urban area were less likely to develop a risk of
poor treatment outcomes as compared to patients who
reside in rural areas (AOR:0.145; 95% CI :0.104,0.201).
Those patients with smear positive (pulmonary TB + ve)
were more likely to have poor treatment outcomes as
compared to patients with EPTB and smear negative pul-
monary TB (AOR = 1.915, 95% CI;1.213,3.028), and HIV
positive TB patients were also more likely to develop risk
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of poor treatment outcomes as compared to their counter-
parts (AOR = 0.796, 95% CI;0.512,1.236) [Table 3].
Discussion
In this facility based retrospective study, data was ex-
tracted from 768 registered TB patients; and the propor-
tion of male patients (55.3%) dominated female patients.
This study was consistent with the finding in Uzbekistan
(60%) [16], Turkey (65%) [17], and at Mizan-Aman gen-
eral hospital (57.2%) [15]. These studies reported an out-
weighed disease proportion of male patients over female
patients. This might be attributed to either males were
more likely to develop the disease or more likely to
utilize the health services than females. However, one
study conducted in Addis Ababa on childhood tubercu-
losis contradicted this finding.
In this study, out of 768 TB patients, 651 (84.8%) were
pulmonary TB patients, and 117 (15.2%) were extra pul-
monary TB patients. And among the pulmonary TB pa-
tients who were registered during the study period, the
majority were affected by smear negative pulmonary TB
(64.7%). And this finding was almost similar with the
study finding conducted in Uzbekistan. In this study,
pulmonary TB (PTB) was present in 77%, of which 43%
were smear-positive and 53% were smear-negative [16],
with the study finding conducted at Mizan- Aman gen-
eral hospital (51.05%) [15], and This finding was also
supported with the study finding conducted in Kwekwe
district, Zimbabwe. In this study 42.4% of patients were
with pulmonary tuberculosis and 8.2% of patients were
with extra pulmonary tuberculosis. And among the pul-
monary TB patients who were registered during the
study period, the majority were affected by smear nega-
tive pulmonary TB (64.7%) [18].
As to TB HIV co-infection; this study reported 16.4%
TB HIV co-infection which was in line with the Ethiop-
ian federal ministry of health report by 2009/10 (15%),
and with the finding observed in the study conducted at
Mizan-Aman general hospital (16.5%) [2, 15]. In this
study, HIV+ve TB patients were more likely to develop
risk of poor treatment outcomes as compared to HIV-ve
TB patients (AOR=0.796, 95% CI;0.512,1.236). This find-
ing was almost in line with the study conducted in a co-
hort of tuberculosis patients in Recife, Pernambuco
state, Brazil and showed that HIV+ve TB patients had
developed poor treatment outcomes as compared to
their counterparts (AOR=3.19, 95% CI; 1.31,7.73), and
with the finding reported from the study conducted in
Kwekwe district, Zimbabwe (RR=2.07, 95% CI;1.12,3.81).
Another [18, 19].
In this study, the overall proportion of cured patients
was 10.9%, which was higher than the proportion ob-
served at the study conducted in Mizan-Aman general
hospital (3.87%) [15]. The difference might be explained
Table 1 Patient characteristics of study subjects, Nigist Eleni
Mohammed General Hospital, June 2009 August 2014














> 65 26 3.4
Tb type
Smear positive 154 20.1
Smear negative 497 64.7
Extra pulmonary TB 117 15.2
TB category
Pulmonary TB 651 84.8
Extra pulmonary TB 117 15.2
Treatment category
New 724 94.3




Table 2 Treatment outcome of study subjects, Nigist Eleni
Mohammed General Hospital, June 2009- August 2014
Variable information frequency Percentage (%)
Treatment out come for all type of TB
Cured 84 10.9
Treatment completed 249 32.4
Died 23 3.0
Failed 4 0.5
Transferred out 397 51.7
Defaulted 11 1.4
Overall treatment outcome
Good treatment outcome 333 43.3
Poor treatment outcome 435 56.7
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due to the high transfer out observed in Mizan-Aman
general hospital (76.99%). In this study, the cure rate of
TB smear positive was 79.39%, which was higher as
compared with the study reported in Addis Ababa
(64.8%) and Mizan-Aman general hospital (62.7%) [14,
15]. This difference might be due to a better access to
health care services and information in the latter
settings.
The defaulting rate in this study (1.4%) revealed lower
finding than the previous studies conducted in Nigist
Eleni general hospital (20%), in Uzbekistan (6%), in
Turkey (3.9%), in hospitals in Imo state, Nigeria (9.8%),
and in Gondar University teaching hospital (36.4%), [16,
17, 20, 21]. This lower defaulting rate in this study might
be due to a better supervision and health education ac-
tivities than the previous study areas.
The overall proportion of death (2.9%) in this study
was lower than the death rate reported in the study con-
ducted in Dessie and Woldiya town health institutions,
Northeast Ethiopia (8.1%), in hospitals in Imo state,
Nigeria (6.5%), in Addis Ababa (4%), in Felege Hiwot re-
ferral hospital, Northwest Ethiopia (5.8%), and in
Kwekwe district, Zimbabwe (8.7%) [14, 18, 20, 22, 23].
The observable higher death rate in the above study
areas might be due to the lack of strict follow up and de-
faulter tracing mechanism. However, the overall death
rate observed in this study was higher than the death
rate observed in Turkey (2.4%) and in Recife, Pernam-
buco state, Brazil (2.8%) [17, 19].
Furthermore, this study reported a treatment failure
rate of 0.5%, which was consistent with the rate of treat-
ment failures reported in Enfraz health center (0.5%)
and in Felege Hiwot referral hospital, Northwest
Ethiopia (0.5%) [23, 24]. However, the treatment failure
reported in this study was slightly higher than the find-
ing in different health centers in Kotabharu, Kelantan,
Malaysia (0.2%), and in Addis Ababa (0.4%) [13, 25]. On
the other hand, the treatment failure observed in this
study was lower than the study findings observed in:
Dessie and Woldiya town health institutions, Northeast
Ethiopia (0.8%), Uzbekistan (3%), Turkey (1.1%), Recife,
Pernambuco state, Brazil (2.1%), hospitals in Imo state,
Nigeria (1.5%), and Kwekwe district, Zimbabwe (0.9%)
[16–20, 22].
There was also a high transfer out rate (51.7%) ob-
served in this study among the patients who registered
for the TB treatment. But this finding was lower than
the study finding in Felege Hiwot referral hospital,
Northwest Ethiopia (68.6%) [23]. This high rate might be
due to the overflow of patients from the rural areas
(53.5%). However, the transferred out cases might have
been cured or successfully completed the treatment. It
could also happen due to unfavorable TB treatment out-
comes like treatment failure and default unless adequate
care and information is considered to the patients. This
means, lack of information about transferred out cases
therefore, limits the strength of reports about treatment
success rate from DOTS clinics.
The overall treatment success of TB was 43.3%, which
was high as compared to the previous finding in Felege
Hiwot referral hospital, Northwest Ethiopia (26%) [23],
but very low as compared to the findings in: Dessie and
Woldiya town health institutions, Northeast Ethiopia
(88.1%), Uzbekistan (83%), Turkey (92.6%), Recife, Per-
nambuco state, Brazil (70.1%), Kotabharu, Kelantan,
Malaysia (93%), hospitals in Imo state, Nigeria (81.4%),
and Kwekwe district, Zimbabwe (72.4%) [16–20, 22, 25].
Possible elucidations for the observed differences be-
tween the findings might be explained due to a high
and/or low transfer out rate in each of the study area.
In this study, residence and treatment outcomes were
highly associated. This means those patients who came
from rural areas were more likely to develop risk of poor
treatment outcomes as compared to patients who reside
in urban areas (AOR=0.145 95% CI; 0.104,0.201). This
finding was parallel with the study findings in:
Table 3 Multivariable logistic regression model predicting treatment outcome, Nigist Eleni Mohammed General Hospital, June 2009
- August 2014
factors category Treatment outcome Crude OR Adjusted OR
(95% CI) (95% CI)
Good treatment outcome poor treatment outcome
N % N %
Residence Rural 92 27.6 323 74.3 0.132 (0.096,0.183) 0.145 (0.104,0.201
Urban 241 72.4 112 25.7 1 1
TB type(category) PTB + ve 92 27.6 62 14.3 2.003(1.334,3.007) 1.915(1.213,3.028
PTB -ve 192 57.7 318 73.1 0.760(0.468,1.234) 0.928(0.538,1.599
Extra pulmonary TB 62 18.6 55 12.6 1 1
HIV Positive 69 20.7 56 12.9 0.565(0.384,0.832) 0.796(0.512,1.236
negative 264 79.3 323 87.1 1 1
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Uzbekistan (AOR=1.3,95% CI;1.2,1.4), Felege Hiwot re-
ferral hospital, Northwest Ethiopia (RR =7.0, 95%
CI;3.89,12.63), and Kwekwe district, Zimbabwe
(AOR=1.91, 95% CI;1.14,3.20) [16, 18, 23].
This might be due to better health seeking behavior of
patients living in the urban areas. Moreover, the health
care institutions might be located nearby the patients
living in urban areas, which in turn might contribute for
a better health seeking behavior and treatment
outcomes.
In this study, there was also a significant association
between treatment out come and TB category. This
means patients who presented pulmonary TB+ve were
more likely to develop risk of poor treatment outcomes
as compared to the patients with extra pulmonary TB
and pulmonary TB-ve (AOR=1.915,95% CI;1.213,3.028).
This finding contradicted the finding that says no signifi-
cant association between unsuccessful treatment out
comes and a status of pulmonary TB patient as reported
in the study finding conducted in Dessie and Woldiya
town health institutions, Northeast Ethiopia (AOR=
0.58, 95% CI; 0.29,1.14), in Enfraz health center, North
west part of Ethiopia, and in Felege Hiwot referral hos-
pital, Northwest Ethiopia (AOR= 1.4, 95% CI; 1.13,1.84).
In these studies, the risk of developing unsuccessful
treatment outcomes was less likely among the pulmon-
ary TB patients than their counterparts [22–24]. This
might happen due to the proportion of TB patients con-
sidered in each category for the study.
In this facility based retrospective study, data was ex-
tracted from 768 registered TB patients; and the propor-
tion of male patients (55.3%) dominated female patients.
This study was consistent with the finding at Mizan-
Aman general hospital (57.2%), Turkey (65%), and
Uzbekistan (60%). [15–17]. These studies reported an
outweighed disease proportion of male patients over fe-
male patients. This might be attributed to either males
were more likely to develop the disease or more likely to
utilize the health services than females. However, one
study conducted in Addis Ababa on childhood tubercu-
losis contradicted this finding. The study showed a high
number of EPTB proportion among female patients [14].
In this study, out of 768 TB patients, 651 (84.8%) were
pulmonary TB patients, and 117 (15.2%) were extra pul-
monary TB patients. This finding was supported with
the study finding conducted in Kwekwe district,
Zimbabwe. In this study 42.4% of patients were pulmon-
ary tuberculosis and 8.2% of patients were extra pulmon-
ary tuberculosis. Among the pulmonary TB patients who
were registered during the study period, the majority
were affected by smear negative pulmonary TB (64.7%).
And this finding was almost similar with the study find-
ing conducted at Mizan- Aman general hospital
(51.05%) [15], and with the study finding conducted at
Uzbekistan. In this study, pulmonary TB (PTB) was
present in 77%, of which 43% were smear-positive and
53% were smear-negative [16].
As to TB HIV co-infection; this study reported
16.4% TB HIV co-infection which was in line with the
Ethiopian federal ministry of health report by 2009/10
(15%) [2], and with the finding observed in the study
conducted at Mizan-Aman general hospital (16.5%) [15].
In this study, HIV + ve TB patients were more likely to
develop risk of poor treatment outcomes as compared to
HIV-ve TB patients (AOR = 0.796, 95% CI;0.512,1.236).
This finding was almost in line with the finding reported
from the study conducted in Kwekwe district, Zimbabwe
(RR = 2.07, 95% CI; 1.12, 3.81). Another study conducted
in a cohort of tuberculosis patients in Recife, Pernam-
buco state, Brazil showed that HIV + ve TB patients had
developed poor treatment outcomes as compared to
their counterparts (AOR = 3.19, 95% CI; 1.31,7.73) [18,
19].
In this study, the overall proportion of cured patients
was 10.9%, which was higher than the proportion ob-
served at the study conducted in Mizan-Aman general
hospital (3.87%). The difference might be explained due
to the high transfer out observed in Mizan-Aman gen-
eral hospital (76.99%). In this study, the cure rate of TB
smear positive was 79.39%, which was higher as com-
pared with the study reported in Addis Ababa (64.8%)
and Mizan-Aman general hospital (62.7%) [14, 15]. This
difference might be due to a better access to health care
services and information in the latter settings.
The defaulting rate in this study (1.4%) revealed lower
finding than the previous studies conducted in Nigist
Eleni general hospital (20%), in Gondar University teach-
ing hospital (36.4%) (24), in Turkey (3.9%), in Uzbekistan
(6%), and in hospitals in Imo state, Nigeria (9.8%) [16,
17, 20, 21]. This lower defaulting rate in this study might
be due to a better supervision and health education ac-
tivities than the previous study areas.
The overall proportion of death (2.9%) in this study
was lower than the death rate reported in the study con-
ducted in Addis Ababa (4%), in Felege Hiwot referral
hospital, Northwest Ethiopia (5.8%), in Dessie and Wol-
diya town health institutions, Northeast Ethiopia (8.1%),
in hospitals in Imo state, Nigeria (6.5%), and in Kwekwe
district, Zimbabwe (8.7%) [12, 14, 18, 20, 22]. The ob-
servable higher death rate in the above study areas might
be due to the lack of strict follow up and defaulter tra-
cing mechanism. However, the overall death rate ob-
served in this study was higher than the death rate
observed in Turkey (2.4%) and in Recife, Pernambuco
state, Brazil (2.8%) [17, 19].
Furthermore, this study reported a treatment failure
rate of 0.5%, which was consistent with the rate of treat-
ment failures reported in Enfraz health center (0.5%)
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and in Felege Hiwot referral hospital, Northwest
Ethiopia (0.5%) [12, 24]. However, the treatment failure
reported in this study was slightly higher than the find-
ing in different health centers in Addis Ababa (0.4%),
and in Kotabharu, Kelantan, Malaysia (0.2%) [13, 25].
On the other hand, the treatment failure observed in this
study was lower than the study findings observed in:
Dessie and Woldiya town health institutions, Northeast
Ethiopia (0.8%), Uzbekistan (3%), Turkey (1.1%), Recife,
Pernambuco state, Brazil (2.1%), hospitals in Imo state,
Nigeria (1.5%), and Kwekwe district, Zimbabwe (0.9%)
[16–20, 22].
There was also a high transfer out rate (51.7%) ob-
served in this study among the patients who registered
for the TB treatment. But this finding was lower than
the study finding in Felege Hiwot referral hospital,
Northwest Ethiopia (68.6%) [12]. This high rate might be
due to the overflow of patients from the rural areas
(53.5%). However, the transferred out cases might have
been cured or successfully completed the treatment. It
could also happen due to unfavorable TB treatment out-
comes like treatment failure and default unless adequate
care and information is considered to the patients. This
means, lack of information about transferred out cases
therefore, limits the strength of reports about treatment
success rate from DOTS clinics.
The overall treatment success of TB was 43.3%, which
was high as compared to the previous finding in Felege
Hiwot referral hospital, Northwest Ethiopia (26%) [12],
but very low as compared to the findings in: Dessie and
Woldiya town health institutions, Northeast Ethiopia
(88.1%), Uzbekistan (83%), Turkey (92.6%), Recife, Per-
nambuco state, Brazil (70.1%), Kwekwe district, Zimbabwe
(72.4%), hospitals in Imo state, Nigeria (81.4%), and
Kotabharu, Kelantan, Malaysia (93%) [16–20, 22, 25]. Pos-
sible elucidations for the observed differences between the
findings might be explained due to a high and/or low
transfer out rate in each of the study area.
In this study, residence and treatment outcomes were
highly associated. This means those patients who came
from rural areas were more likely to develop risk of poor
treatment outcomes as compared to patients who reside in
urban areas (AOR= 0.145 95% CI; 0.104,0.201). This finding
was parallel with the study findings in: Felege Hiwot referral
hospital, Northwest Ethiopia (RR = 7.0, 95% CI;3.89,12.63),
Uzbekistan (AOR= 1.3,95% CI;1.2,1.4), and Kwekwe dis-
trict, Zimbabwe (AOR= 1.91, 95% CI;1.14,3.20) [12, 16, 18].
This might be due to better health seeking behavior of
patients living in the urban areas. Moreover, the health
care institutions might be located nearby the patients liv-
ing in urban areas, which in turn might contribute for a
better health seeking behavior and treatment outcomes.
In this study, there was also a significant association
between treatment out come and TB category. This
means patients who presented pulmonary TB + ve were
more likely to develop risk of poor treatment outcomes
as compared to the patients with extra pulmonary TB
and pulmonary TB-ve (AOR = 1.915,95% CI;1.213,3.028).
This finding was in opposite to the study finding con-
ducted in Dessie and Woldiya town health institutions,
Northeast Ethiopia (AOR = 0.58, 95% CI; 0.29,1.14), and
in Felege Hiwot referral hospital, Northwest Ethiopia
(AOR = 1.4, 95% CI; 1.13,1.84). In these studies, the risk
of developing unsuccessful treatment outcomes was less
likely among the pulmonary TB patients than the extra
pulmonary TB patients [12, 22]. This might happen due
to the proportion of TB patients considered in each cat-
egory for the study. On the other hand, patients with
smear positive (pulmonary TB + ve) were more likely to
develop a risk of poor treatment outcomes as compared
to smear negative (pulmonary TB-ve) patients (AOR =
1.915 95% CI;1.213,3.028). This result contradicted the
finding that says no significant association between un-
successful treatment out comes and a status of pulmon-
ary TB patient as reported in Enfraz health center in
North west part of Ethiopia [24].
Conclusion
From this study it was generally observed that the rate
of defaulters was very low in the hospital. On the other
hand, it was observed that the rate of transfer out of pa-
tients from the hospital to other health care facilities
was very high during the study period.
TB classification, residence and HIV status of the
patients were found significantly associated with TB
treatment outcomes, and patients who came from urban
area were less likely to come up with poor treatment
outcome as compared to patients who reside in rural areas.
Furthermore, it was observed that those patients with
pulmonary smear positive (pulmonary TB + ve) and
those with the history of HIV (HIV + ve) were more
likely to develop risk of poor treatment outcomes as
compared to their counterparts.
Recommendations
To zonal health department and NEMGH
During the study period there was a significant number
of patient transfer out. Therefore, based on this finding,
it is better for the hospital and zonal health department
to carry out a strict and frequent supervision to access
the relevant information regarding the treatment outcome
of the patients from the accepting health care facilities.
From the study, it was observed that there was poor
treatment outcomes among the patients coming from the
rural areas. Therefore, the hospital and zonal health de-
partment has to enable the rural population with educa-
tional, environmental, organisational and other relevant
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facilities, so that the health seeking behavior of the popu-
lation towards TB will be improved.
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